General Investing >> Analyst Interviews >> March 4, 2004
KEE COLEN, Senior Vice President, has been providing investment banking
services to emerging growth and middle market companies for 15 years.
His industry focus is health care, including the biotechnology,
specialty pharmaceutical and medical technology sectors. He has
completed over 75 transactions including initial and follow-on public
offerings, PIPEs, other private placements of equity, mezzanine and debt
capital, M&A advisory, valuations and fairness opinions. He joined
Oppenheimer's predecessor, Fahnestock & Co. Inc., in 1994 through the
acquisition of Reich & Co. Inc. Prior to Reich, he was an Investment
Banking Associate at Rosenkrantz, Lyon & Ross and a Research Analyst in
the municipal bond department at Van Kampen Merritt. He has a BS in
Finance from Northern Illinois University where he graduated magna cum
laude and an MBA from Indiana University. Profile
space? It seems to have finally gotten better, hasn't it?
Mr. Colen: It has. Last year NASDAQ was up significantly, and
